FDA-001: Introduction to Schedule Forensic Delay Analysis
This course provides in-depth training on the principles behind Schedule Forensic Delay Analysis. It commences with the fundamentals of creating a quality CPM Programme and investigates how to interrogate the quality of a Programme against the DCMA 14-Point Schedule assessment and in line with the US Government Accountability Office (GAO) Schedule Assessment Guide. We will also review the Society of Construction Law (SCL) Delay & Disruption protocol, whilst ensuring material aligns with planning and scheduling best practices. We will then introduce delay analysis techniques, and discuss current contractual issues that impact the handling of delays.
We will interrogate sample scenarios and how to review these programmes based against the various methods of delay techniques taught in the class.
- Understand the fundamental principles behind CPM Programmes
- Interrogate the quality of a Programme
- Have an understanding of the DCMA 14-Point Analysis
- Have an understanding of the US GAO Schedule Assessment
- Have an understanding of the SCL Delay & Disruption Protocol
- Differentiate between the different forms of Delay Analysis
- As-Planned Vs As-Built
- Impacted As-Built
- Collapsed As-Built
- Time Impact Analysis
- Windows Analysis
- As-Planned Vs As-Built in Windows
- Deliver effective presentations of Delay Analysis
Prerequisite: No prior knowledge required but a basic understanding of Planning & Scheduling is an advantage but not a necessity.
Delegate Profile: Planners, Schedulers, Quantity Surveyors, Engineers, Project Managers,
Trainer Profile: The course will be delivered by instructors with decades of experience in Planning & Scheduling
Course Length: 3-days (09.30am till 4.00pm)
Course Price: €1500 per person (coffee breaks/refreshments and lunch is provided each day)
***Payment must be received in full upon registering in order to secure your place***
At the completion of this course the student will be able to:
- Understand CPM scheduling techniques
- Analyse quality of a Programme
- Identify a construed Critical Path
- Understand Contract requirements in relation to the Programme
- Differentiate between prolongation and elongation
- Display schedule delays based on variety of delay methods
- Understand requirements based around quality of details for As-Built information
- Capture impacts against a Programme in an organised way during the life cycle of the project
Schedule Forensic Delay Analysis: Introduction and course overview
Forensic Delay Analysis (FDA) can be defined as “the study of event interaction using the critical path method of scheduling to understand the significance of deviations from a baseline for potential use in legal proceedings”. More simply put, FDA is about examining what actually happened on a project, how it differed from the original plan, whose fault it was, what effect it had, and ultimately being able to use this information to back up or contest a claim in court.
Forensic delay analysis, like many other technical fields, is both a science and an art. As such, it relies upon professional judgment and expert opinion and usually requires many subjective decisions. One of the most important of these decisions is what technical approach should be used to measure or quantify delay and identify the affected activities in order to focus on causation (cause and effect). Equally important is how the analyst should apply the chosen method. Professional judgment and expert opinion ultimately rest on subjectivity, but that subjectivity must be based on diligent factual research and objective analysis of the results.
In this course, you will be introduced to many topics that will prepare you to understand forensic delay analysis. A prerequisite to FDA is a thorough understanding of the critical path method of scheduling, so that you can fully understand the impact of schedule deviations. Therefore, we start with a review of CPM, and a discussion of the importance of developing a quality baseline schedule. Note that Oracle Primavera P6 is the software tool that we have chosen for illustrating CPM and other schedule examples.
We will then examine what constitutes a deviation from the plan, and how we can record progress and identify delays on an updated schedule. This will lead into an in-depth discussion of the various methods of delay analysis, highlighting their advantages and disadvantages. Some general guidelines will be given for choosing the appropriate method for different situations. However, it will ultimately be a decision for your team and you as to which method to use for any particular schedule, based on the evidence to hand and the expertise available to you.
Finally, we will introduce common types of contracts, and discuss contractual requirements with regard to schedule delays and give some presentation of current construction law protocols
It is important to recognize that no forensic delay analysis method is exact. The level of accuracy of the answers produced by each method is a function of the quality of the data used therein, the accuracy of the assumptions, and the subjective judgments made by the forensic schedule analyst. But regardless of method there is one common theme throughout all and that is the importance of a quality schedule and the availability of verifiable records to backup your position.
Tony Harkins - Senior Consultant
B.E. (Civil), C.Eng, Eur. Ing. (FEANI), F.I.E.I., F.C.I.Arb. (Chartered Institute of Arbitrators) D.A.L. (Diploma in Arbitration Law) & D.I.A.L. (Diploma in International Arbitration Law), Certificate in European Law, D.L.S. (Diploma in Legal Studies), Dip.E.I.A.Mgt, Dip Mediation Studies
Tony is an expert on Claims Processes (Ireland's 6 public works contracts & RIAI, IEI Forms of Contracts, FIDIC Internationally, NEC3 in the UK and others) and has successfully worked on Delay Analysis Interpretation, Dispute Resolution and the Arbitration - Mediation - Conciliation processes for numerous clients.
Raymond Poole - Managing Director PMIS Ltd.
M.I.E.I. Dip Eng., Dip A.D.R., Dip in PM
Raymond, the Founding Director of PMIS Ltd and the PM Summit, has been actively engaged within the EPPM sector since 1980, having worked on and led multiple projects in Ireland and overseas and has successfully presented FDA at numerous disputes. He is currently pursuing a Master’s degree in Project and Programme Management at The University of Limerick.
Sinead Walsh - Director, US Operations at PMIS Inc.
Grad Cert. PM, PhD (Chemistry)
Sinead has worked on a number of global projects during her employment with Bristol-Myers Squibb and Rhodia-ChiRex. During this time she became adapt at Project and Risk Management techniques. She honed her skills in relation to Stakeholder Management, managing teams whilst maintaining tight deadlines and keeping focussed on the scope requirements for a diverse range of Pharmaceutical Projects. She has also qualified with a Graduate Certificate in Project Management from the Boston University